O	O	O	0	1	[	[	O	(	O	4	NMOD	O
O	O	O	1	11	Corticoids	Corticoid	B-NP	NNS	O	4	NMOD	O
O	O	O	12	15	and	and	O	CC	O	4	NMOD	O
O	O	O	16	23	allergy	allergy	B-NP	NN	O	0	ROOT	O
O	O	O	23	24	]	]	O	)	O	4	NMOD	O

O	O	O	26	38	Inflammation	Inflammation	B-NP	NN	O	2	SUB	O
O	O	O	39	41	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	42	52	constantly	constantly	I-VP	RB	O	4	VMOD	O
O	O	O	53	61	observed	observe	I-VP	VBN	O	2	VC	O
O	O	O	62	64	in	in	B-PP	IN	O	4	VMOD	O
O	O	O	65	73	allergic	allergic	B-NP	JJ	O	7	NMOD	O
O	O	O	74	83	reactions	reaction	I-NP	NNS	O	5	PMOD	O
O	O	O	83	84	.	.	O	.	O	2	P	O

O	O	O	85	100	Corticosteroids	Corticosteroid	B-NP	NNS	O	2	SUB	O
O	O	O	101	104	are	be	B-VP	VBP	O	0	ROOT	O
O	O	O	105	109	most	most	B-ADJP	RBS	O	4	AMOD	O
O	O	O	110	119	effective	effective	I-ADJP	JJ	O	2	PRD	O
O	O	O	120	122	in	in	B-PP	IN	O	2	VMOD	O
O	O	O	123	133	preventing	prevent	B-VP	VBG	O	5	PMOD	O
O	O	O	134	137	the	the	B-NP	DT	O	9	NMOD	O
O	O	O	138	142	late	late	I-NP	JJ	O	9	NMOD	O
O	O	O	143	148	phase	phase	I-NP	NN	O	6	OBJ	O
O	O	O	149	151	of	of	B-PP	IN	O	9	NMOD	O
O	O	O	152	160	allergic	allergic	B-NP	JJ	O	12	NMOD	O
O	O	O	161	169	reaction	reaction	I-NP	NN	O	10	PMOD	O
O	O	O	169	170	.	.	O	.	O	2	P	O

O	O	O	171	174	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	175	181	action	action	I-NP	NN	O	5	SUB	O
O	O	O	182	184	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	185	205	glucocorticosteroids	glucocorticosteroid	B-NP	NNS	O	3	PMOD	O
O	O	O	206	208	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	209	217	mediated	mediate	I-VP	VBN	O	5	VC	O
O	O	O	218	225	through	through	B-PP	IN	O	6	VMOD	O
O	O	O	226	240	glucocorticoid	glucocorticoid	B-NP	NN	B-protein	9	NMOD	B-protein
O	O	O	241	250	receptors	receptor	I-NP	NNS	I-protein	7	PMOD	I-protein
O	O	O	251	258	present	present	B-ADJP	JJ	O	9	NMOD	O
O	O	O	259	261	in	in	B-PP	IN	O	10	AMOD	O
O	O	O	262	265	the	the	B-NP	DT	O	14	NMOD	O
O	O	O	266	274	cellular	cellular	I-NP	JJ	O	14	NMOD	O
O	O	O	275	284	cytoplasm	cytoplasm	I-NP	NN	O	11	PMOD	O
O	O	O	284	285	.	.	O	.	O	5	P	O

O	O	O	286	290	When	When	B-ADVP	WRB	O	6	VMOD	O
O	O	O	291	300	activated	activate	B-VP	VBN	O	1	SBAR	O
O	O	O	300	301	,	,	O	,	O	6	P	O
T1	B-Entity	B-Entity	302	316	glucocorticoid	glucocorticoid	B-NP	NN	B-protein	5	NMOD	B-protein
T1	I-Entity	I-Entity	317	326	receptors	receptor	I-NP	NNS	I-protein	6	SUB	I-protein
O	O	O	327	331	form	form	B-VP	VBP	O	0	ROOT	O
O	O	O	332	333	a	a	B-NP	DT	O	8	NMOD	O
T2	B-Entity	B-Entity	334	339	dimer	dimer	I-NP	NN	B-protein	6	OBJ	B-protein
O	O	O	340	343	and	and	O	CC	O	6	VMOD	O
O	O	O	344	348	bind	bind	B-VP	VBP	O	6	VMOD	O
O	O	O	349	351	to	to	B-PP	TO	O	10	VMOD	O
T3	B-Entity	B-Entity	352	355	DNA	DNA	B-NP	NN	O	11	PMOD	O
O	O	O	356	361	after	after	B-PP	IN	O	10	VMOD	O
O	O	O	362	371	migration	migration	B-NP	NN	O	13	PMOD	O
O	O	O	372	376	into	into	B-PP	IN	O	14	NMOD	O
O	O	O	377	380	the	the	B-NP	DT	O	17	NMOD	O
O	O	O	381	388	nucleus	nucleus	I-NP	NN	O	15	PMOD	O
O	O	O	388	389	.	.	O	.	O	6	P	O

O	O	O	390	401	Interaction	Interaction	B-NP	NN	O	4	SUB	O
O	O	O	402	404	to	to	B-PP	TO	O	1	NMOD	O
T4	B-Entity	B-Entity	405	408	DNA	DNA	B-NP	NN	O	2	PMOD	O
O	O	O	409	416	induces	induce	B-VP	VBZ	O	0	ROOT	O
O	O	O	417	424	changes	change	B-NP	NNS	O	4	OBJ	O
O	O	O	425	427	in	in	B-PP	IN	O	5	NMOD	O
O	O	O	428	431	the	the	B-NP	DT	O	9	NMOD	O
O	O	O	432	445	transcription	transcription	I-NP	NN	O	9	NMOD	O
O	O	O	446	450	rate	rate	I-NP	NN	O	6	PMOD	O
O	O	O	450	451	,	,	O	,	O	5	P	O
O	O	O	452	459	leading	lead	B-VP	VBG	O	5	NMOD	O
O	O	O	460	462	to	to	B-PP	TO	O	11	VMOD	O
O	O	O	463	469	either	either	B-NP	CC	O	18	NMOD	O
T5	B-Entity	B-Entity	470	474	gene	gene	I-NP	NN	O	15	NMOD	O
O	O	O	475	484	induction	induction	I-NP	NN	O	18	NMOD	O
O	O	O	485	487	or	or	I-NP	CC	O	18	NMOD	O
T6	B-Entity	B-Entity	488	492	gene	gene	I-NP	NN	O	18	NMOD	O
O	O	O	493	503	repression	repression	I-NP	NN	O	12	PMOD	O
O	O	O	503	504	.	.	O	.	O	4	P	O

O	O	O	505	519	Glucocorticoid	Glucocorticoid	B-NP	NN	B-protein	2	NMOD	B-protein
O	O	O	520	529	receptors	receptor	I-NP	NNS	I-protein	3	SUB	I-protein
O	O	O	530	533	are	be	B-VP	VBP	O	0	ROOT	O
O	O	O	534	538	also	also	B-ADVP	RB	O	3	VMOD	O
O	O	O	539	543	able	able	B-ADJP	JJ	O	3	PRD	O
O	O	O	544	546	to	to	B-VP	TO	O	7	VMOD	O
O	O	O	547	555	interact	interact	I-VP	VB	O	5	AMOD	O
O	O	O	556	560	with	with	B-PP	IN	O	7	VMOD	O
O	O	O	561	576	transcriptional	transcriptional	B-NP	JJ	B-protein	10	NMOD	B-protein
O	O	O	577	584	factors	factor	I-NP	NNS	I-protein	8	PMOD	I-protein
O	O	O	585	589	such	such	B-PP	JJ	O	12	PMOD	O
O	O	O	590	592	as	as	I-PP	IN	O	22	VMOD	O
T7	B-Entity	B-Entity	593	595	AP	AP	B-NP	NN	B-protein	14	NMOD	B-protein
T7	I-Entity	I-Entity	595	596	-	-	B-NP	HYPH	I-protein	22	P	I-protein
T7	I-Entity	I-Entity	596	597	1	1	I-NP	CD	I-protein	14	NMOD	I-protein
O	O	O	598	599	(	(	O	(	O	21	DEP	O
T8	B-Entity	B-Entity	599	608	activator	activator	B-NP	NN	B-protein	18	NMOD	B-protein
T8	I-Entity	I-Entity	609	616	protein	protein	I-NP	NN	I-protein	20	NMOD	I-protein
T8	I-Entity	I-Entity	616	617	-	-	B-NP	HYPH	O	20	P	O
T8	I-Entity	I-Entity	617	618	1	1	I-NP	CD	O	21	DEP	O
O	O	O	618	619	)	)	O	)	O	14	NMOD	O
O	O	O	620	622	of	of	B-PP	IN	O	10	NMOD	O
T9	B-Entity	B-Entity	623	625	NF	NF	B-NP	NN	B-protein	26	NMOD	B-protein
T9	I-Entity	I-Entity	625	626	-	-	O	HYPH	I-protein	26	NMOD	I-protein
T9	I-Entity	I-Entity	626	631	kappa	kappa	B-NP	NN	I-protein	26	NMOD	I-protein
T9	I-Entity	I-Entity	632	633	B	B	I-NP	NN	I-protein	22	PMOD	I-protein
O	O	O	634	635	(	(	O	(	O	33	DEP	O
T10	B-Entity	B-Entity	635	642	nuclear	nuclear	B-NP	JJ	B-protein	32	NMOD	B-protein
T10	I-Entity	I-Entity	643	649	factor	factor	I-NP	NN	I-protein	32	NMOD	I-protein
T10	I-Entity	I-Entity	649	650	-	-	B-NP	HYPH	I-protein	32	P	I-protein
T10	I-Entity	I-Entity	650	655	kappa	kappa	I-NP	NN	I-protein	32	NMOD	I-protein
T10	I-Entity	I-Entity	656	657	B	B	I-NP	NN	I-protein	33	DEP	I-protein
O	O	O	657	658	)	)	O	)	O	26	NMOD	O
O	O	O	658	659	.	.	O	.	O	3	P	O

O	O	O	660	667	Through	Through	B-PP	IN	O	5	VMOD	O
O	O	O	668	673	these	these	B-NP	DT	O	3	NMOD	O
O	O	O	674	681	actions	action	I-NP	NNS	O	1	PMOD	O
O	O	O	682	702	glucocorticosteroids	glucocorticosteroid	B-NP	NNS	O	5	SUB	O
O	O	O	703	706	are	be	B-VP	VBP	O	0	ROOT	O
O	O	O	707	718	susceptible	susceptible	B-ADJP	JJ	O	5	PRD	O
O	O	O	719	721	to	to	B-VP	TO	O	8	VMOD	O
O	O	O	722	728	modify	modify	I-VP	VB	O	6	AMOD	O
O	O	O	729	738	functions	function	B-NP	NNS	O	8	OBJ	O
O	O	O	739	741	of	of	B-PP	IN	O	9	NMOD	O
O	O	O	742	747	cells	cell	B-NP	NNS	O	10	PMOD	O
O	O	O	748	756	involved	involve	B-VP	VBN	O	11	NMOD	O
O	O	O	757	759	in	in	B-PP	IN	O	12	VMOD	O
O	O	O	760	763	the	the	B-NP	DT	O	17	NMOD	O
O	O	O	764	772	allergic	allergic	I-NP	JJ	O	17	NMOD	O
O	O	O	773	785	inflammatory	inflammatory	I-NP	JJ	O	17	NMOD	O
O	O	O	786	794	response	response	I-NP	NN	O	13	PMOD	O
O	O	O	794	795	.	.	O	.	O	5	P	O

O	O	O	796	800	They	They	B-NP	PRP	O	2	SUB	O
O	O	O	801	804	are	be	B-VP	VBP	O	0	ROOT	O
O	O	O	805	807	in	in	B-PP	IN	O	2	VMOD	O
O	O	O	808	818	particular	particular	B-NP	JJ	O	3	PMOD	O
O	O	O	819	823	able	able	I-NP	JJ	O	2	PRD	O
O	O	O	824	826	to	to	B-VP	TO	O	7	VMOD	O
O	O	O	827	834	inhibit	inhibit	I-VP	VB	O	5	AMOD	O
O	O	O	835	839	most	most	B-NP	JJS	O	7	OBJ	O
O	O	O	840	842	of	of	B-PP	IN	O	8	NMOD	O
O	O	O	843	846	the	the	B-NP	DT	O	14	NMOD	O
O	O	O	847	850	pro	pro	I-NP	AFX	B-DNA	14	NMOD	B-DNA
O	O	O	850	851	-	-	I-NP	HYPH	O	14	NMOD	O
O	O	O	851	863	inflammatory	inflammatory	I-NP	JJ	O	14	NMOD	O
O	O	O	864	873	functions	function	I-NP	NNS	O	9	PMOD	O
O	O	O	874	876	of	of	B-PP	IN	O	14	NMOD	O
O	O	O	877	880	the	the	B-NP	DT	O	17	NMOD	O
O	O	O	881	892	eosinophils	eosinophil	I-NP	NNS	B-cell_type	15	PMOD	B-cell_type
O	O	O	892	893	.	.	O	.	O	2	P	O
